This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dhar, D. K. Articles by Nagasue, N. Search for Related Content PubMed PubMed Citation Articles by Dhar, D. K. Articles by Nagasue, N.

Expression of Trefoil Factor Family Members Correlates with Patient Prognosis and Neoangiogenesis

Authors' Affiliations: Departments of ¹ Digestive and General Surgery and ² Central Pathological Laboratory, Faculty of Medicine; Shimane University, ³ Department of Surgery, Izumo Citizen Hospital, Izumo; ⁴ Naze Tokushukai Hospital, Kagoshima, Japan; and ⁵ Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, New York

Requests for reprints: Mitsuo Tachibana, Department of Digestive and General Surgery, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan. Phone: 81-853-202235; Fax: 81-853-202229; E-mail: nigeka35{at}shimane-med.ac.jp.

Purpose: Trefoil factor family (TFF) peptides are thought to contribute to epithelial protection and restitution by virtue of their protease-resistant nature and their strong affinity for mucins. However, they are often overexpressed in tumors, where they seem to be negative prognostic factors, possibly contributing to tumor spread, although the precise mechanisms have not been defined.

Experimental Design: Tissue sections from 111 patients with curatively resected advanced gastric carcinoma were immunohistochemically stained for TFF2, ITF (TFF3), and CD34. Microvessel density was expressed as number and area of microvessels. Results were correlated with clinicopathological characteristics and patient survival.

Results: Forty-nine (44.1%) and 41 (36.9%) tumors were immunohistochemically positive for TFF3 and TFF2, respectively. Among the various clinicopathologic variables, overexpression of TFF3 had a significant correlation with patient age only. In addition, a significantly higher prevalence of positive TFF2 staining was detected in large, diffuse tumors and in tumors with lymph node metastasis. The number of microvessels had a significant correlation with both TFF3 and TFF2 staining, whereas the area of microvessels had a significant correlation only with TFF3 staining. Both TFF3 and TFF2 were independent predictors of a worse disease-free survival. TFF3 had a gender-specific negative survival advantage, with a 91.3% disease-free survival in female patients with TFF3-negative advanced gastric carcinoma.

Conclusions: Induction of increased tumor vascularity might be one of the mechanisms by which TFFs confer metastatic phenotype and frequent disease recurrence in gastric carcinomas. Female patients with TFF3-negative advanced gastric carcinoma have comparable survival as that reported for patients with early gastric carcinoma.

This article has been cited by other articles:

				S. F. Moss, J.-W. Lee, E. Sabo, A. K. Rubin, J. Rommel, B. R. Westley, F. E.B. May, J. Gao, P. A. Meitner, R. Tavares, et al. Decreased Expression of Gastrokine 1 and the Trefoil Factor Interacting Protein TFIZ1/GKN2 in Gastric Cancer: Influence of Tumor Histology and Relationship to Prognosis Clin. Cancer Res., July 1, 2008; 14(13): 4161 - 4167. [Abstract] [Full Text] [PDF]